US 11236102
Oxabicycloheptane prodrugs
granted A61KA61K31/337A61K31/34
Quick answer
US patent 11236102 (Oxabicycloheptane prodrugs) held by Lixte Biotechnology, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/337, A61K31/34, A61K31/496, A61K45/06